EN
Revenue Beat: Galaxy Surfactants Limited Exceeded Revenue Forecasts By 8.0% And Analysts Are Updating Their Estimates
It's been a good week for Galaxy Surfactants Limited (NSE:GALAXYSURF) shareholders, because the company has just released its latest quarterly results, and the shares gained 3.0% to ₹2,179. Results overall were respectable, with statutory earnings of ₹33.67 per share roughly in line with what the analysts had forecast. Revenues of ₹18b came in 8.0% ahead of analyst predictions. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Taking into account the latest results, the current consensus from Galaxy Surfactants' nine analysts is for revenues of ₹66.9b in 2027. This would reflect a credible 7.4% increase on its revenue over the past 12 months. Statutory per-share earnings are expected to be ₹116, roughly flat on the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of ₹62.1b and earnings per share (EPS) of ₹116 in 2027. So it looks like there's been no major change in sentiment following the latest results, although the analysts have made a small increase to to revenue forecasts.
View our latest analysis for Galaxy Surfactants
Even though revenue forecasts increased, there was no change to the consensus price target of ₹2,694, suggesting the analysts are focused on earnings as the driver of value creation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Galaxy Surfactants analyst has a price target of ₹3,448 per share, while the most pessimistic values it at ₹2,228. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Galaxy Surfactants' growth to accelerate, with the forecast 15% annualised growth to the end of 2027 ranking favourably alongside historical growth of 8.7% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 12% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Galaxy Surfactants to grow faster than the wider industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. The consensus price target held steady at ₹2,694, with the latest estimates not enough to have an impact on their price targets.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Galaxy Surfactants going out to 2029, and you can see them free on our platform here.
However, before you get too enthused, we've discovered 2 warning signs for Galaxy Surfactants that you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.